🔗 Permalink

Inventor profile of:

Jay Rothstein

City:

Norwich, Vermont

Country:

United States

Published Applications:

Last publication date:

2025-11-13

Top Assignees for applications by Jay Rothstein

The entities that hold a legal rights for patent applications filed by inventor Rothstein Jay:

IMMUNEXT INC. 8 Lebanon, NH United States
JANSSEN PHARMACEUTICALS, INC. 2 Raritan, NJ United States
Janssen Pharmaceutical N.V. 2 Beerse, Belgium
ImmuNext, Inc. 1 Lebanon, NJ United States
The Trustees of Dartmouth College 1 Hanover, NH United States

Recent patent applications by Rothstein Jay

Jay Rothstein from Norwich, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-11-13

US20250346666A1

Chemistry; metallurgy

ANTI-HUMAN VISTA ANTIBODIES AND USE THEREOF

#2 | 2025-08-21

US20250263485A1

Chemistry; metallurgy

ANTI-HUMAN VISTA ANTIBODIES AND USE THEREOF

#3 | 2025-08-21

US20250263484A1

Chemistry; metallurgy

ANTI-HUMAN VISTA ANTIBODIES AND USE THEREOF

#4 | 2025-04-03

US20250108119A1

Human necessities

NOVEL STEROID PAYLOADS, STEROID LINKERS, ADCs CONTAINING AND USE THEREOF

#5 | 2024-05-02

US20240141037A1

Chemistry; metallurgy

ANTI-HUMAN VISTA ANTIBODIES AND USE THEREOF

#6 | 2024-02-29

US20240067719A1

Chemistry; metallurgy

ANTI-HUMAN VISTA ANTIBODIES AND USE THEREOF

#7 | 2024-01-18

US20240018238A1

Chemistry; metallurgy

ANTI-HUMAN VISTA ANTIBODIES AND USE THEREOF

#8 | 2024-01-04

US20240000929A1

Human necessities

ANTI-CD154 ANTIBODY HAVING IMPROVED BINDING, FUNCTIONAL AND SAFETY CHARACTERISTICS AND USE IN HUMAN IMMUNOTHERAPY

#9 | 2022-08-18

US20220259310A1

Chemistry; metallurgy

ANTI-HUMAN VISTA ANTIBODIES AND USE THEREOF

#10 | 2021-10-14

US20210317207A1

Chemistry; metallurgy

ANTI-HUMAN VISTA ANTIBODIES AND USE THEREOF

#11 | 2021-10-14

US20210317206A1

Chemistry; metallurgy

ANTI-HUMAN VISTA ANTIBODIES AND USE THEREOF

#12 | 2021-05-20

US20210145966A1

Human necessities

Methods of immunosuppression comprising administering an anti-CD154 antibody

#13 | 2021-01-21

US20210017281A1

Chemistry; metallurgy

ANTI-HUMAN VISTA ANTIBODIES AND USE THEREOF

#14 | 2020-06-25

US20200199254A1

Chemistry; metallurgy

IDENTIFICATION OF VSIG8 AS THE PUTATIVE VISTA RECEPTOR (V-R) AND USE THEREOF TO PRODUCE VISTA/VSIG8 AGONISTS AND ANTAGONISTS

#15 | 2019-10-31

US20190330349A1

Chemistry; metallurgy

Anti-human VISTA antibodies and use thereof

#16 | 2018-07-12

US20180193454A1

Human necessities

Anti-CD154 antibody having improved binding, functional and safety characteristics

#17 | 2018-03-22

US20180079811A1

Chemistry; metallurgy

Anti-human vista antibodies and use thereof

#18 | 2017-10-26

US20170306024A1

Chemistry; metallurgy

Anti-human vista antibodies and use thereof

#19 | 2017-10-26

US20170306023A1

Chemistry; metallurgy

Anti-human vista antibodies and use thereof

#20 | 2017-10-26

US20170306022A1

Chemistry; metallurgy

ANTI-HUMAN VISTA ANTIBODIES AND USE THEREOF

#21 | 2017-10-26

US20170306021A1

Chemistry; metallurgy

ANTI-HUMAN VISTA ANTIBODIES AND USE THEREOF

#22 | 2017-10-26

US20170306020A1

Chemistry; metallurgy

ANTI-HUMAN VISTA ANTIBODIES AND USE THEREOF

#23 | 2017-10-26

US20170306019A1

Chemistry; metallurgy

Anti-human vista antibodies and use thereof

#24 | 2016-06-09

US20160159927A1

Chemistry; metallurgy

Identification of VSIG8 as the putative VISTA receptor (V-R) and use thereof to produce VISTA/VSIG8 agonists and antagonists

InventorID:

1553450 ⎘